AbbVie Inc. (0QCV.L)
LSE - LSE Delayed price. Currency in EUR
Add to watchlist
89.63+9.15 (+11.37%)
As of 11:39AM GMT. Market open.
| Previous close | 80.48 |
| Open | 104.39 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 104.39 - 104.39 |
| 52-week range | 104.39 - 104.39 |
| Volume | 400 |
| Avg. volume | N/A |
| Market cap | 133.665B |
| Beta (5Y monthly) | 0.80 |
| PE ratio (TTM) | 30.77 |
| EPS (TTM) | 2.91 |
| Earnings date | 29 Jul 2021 - 02 Aug 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Editor's pickYahoo Finance Video
FDA ‘shifting the bar’ for approval with new Alzheimer’s drug: Eli Lilly CEO
Eli Lilly CEO David Ricks joins 'Influencers with Andy Serwer' to discuss the FDA's approval of Biogen's new Alzheimer’s drug.
- Simply Wall St.
AbbVie Inc. (NYSE:ABBV) Delivered A Better ROE Than Its Industry
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
- Simply Wall St.
Here's Why Shareholders May Want To Be Cautious With Increasing AbbVie Inc.'s (NYSE:ABBV) CEO Pay Packet
CEO Rick Gonzalez has done a decent job of delivering relatively good performance at AbbVie Inc. ( NYSE:ABBV...
© 2021 Verizon Media. All rights reserved.
